GUMDROP : UMD - An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Created by Nancy Dawson, last modified on Jun 25, 2013
Description:This is a trial of AGS-003, which is being studied as a possible treatment for Advanced Renal Cell Carcinoma. The purpose of this study is to determine whether there is an overall survival (OS) benefit between subjects treated with AGS-003 in combination with standard treatment versus subjects treated with standard treatment alone.
Link:http://clinicaltrials.gov/ct2/show/NCT01582672
Site:University of Maryland
Principal Investigator:Heather Mannuel, MD